Annual CAPEX:
$22.90M-$28.70M(-55.62%)Summary
- As of today, EBS annual capital expenditures is $22.90 million, with the most recent change of -$28.70 million (-55.62%) on December 31, 2024.
- During the last 3 years, EBS annual CAPEX has fallen by -$201.20 million (-89.78%).
- EBS annual CAPEX is now -93.63% below its all-time high of $359.50 million, reached on December 31, 2022.
Performance
EBS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$3.40M+$500.00K(+17.24%)Summary
- As of today, EBS quarterly capital expenditures is $3.40 million, with the most recent change of +$500.00 thousand (+17.24%) on September 30, 2025.
- Over the past year, EBS quarterly CAPEX has dropped by -$2.40 million (-41.38%).
- EBS quarterly CAPEX is now -98.75% below its all-time high of $271.60 million, reached on September 30, 2022.
Performance
EBS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$11.60M-$2.40M(-17.14%)Summary
- As of today, EBS TTM capital expenditures is $11.60 million, with the most recent change of -$2.40 million (-17.14%) on September 30, 2025.
- Over the past year, EBS TTM CAPEX has dropped by -$21.00 million (-64.42%).
- EBS TTM CAPEX is now -96.96% below its all-time high of $381.70 million, reached on September 30, 2022.
Performance
EBS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -55.6% | -41.4% | -64.4% |
| 3Y3 Years | -89.8% | -98.8% | -97.0% |
| 5Y5 Years | -73.7% | -92.6% | -91.8% |
EBS CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -93.6% | at low | -98.8% | +100.0% | -97.0% | at low |
| 5Y | 5-Year | -93.6% | at low | -98.8% | +100.0% | -97.0% | at low |
| All-Time | All-Time | -93.6% | +455.4% | -98.8% | +100.0% | -97.0% | +30.4% |
EBS CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $3.40M(+17.2%) | $11.60M(-17.1%) |
| Jun 2025 | - | $2.90M(-19.4%) | $14.00M(-10.8%) |
| Mar 2025 | - | $3.60M(+111.8%) | $15.70M(-31.4%) |
| Dec 2024 | $22.90M(-55.6%) | $1.70M(-70.7%) | $22.90M(-29.8%) |
| Sep 2024 | - | $5.80M(+26.1%) | $32.60M(-17.3%) |
| Jun 2024 | - | $4.60M(-57.4%) | $39.40M(-16.7%) |
| Mar 2024 | - | $10.80M(-5.3%) | $47.30M(-8.3%) |
| Dec 2023 | $51.60M(-85.6%) | $11.40M(-9.5%) | $51.60M(-19.1%) |
| Sep 2023 | - | $12.60M(+0.8%) | $63.80M(-80.2%) |
| Jun 2023 | - | $12.50M(-17.2%) | $322.80M(-5.7%) |
| Mar 2023 | - | $15.10M(-36.0%) | $342.40M(-4.8%) |
| Dec 2022 | $359.50M(+60.4%) | $23.60M(-91.3%) | $359.50M(-5.8%) |
| Sep 2022 | - | $271.60M(+746.1%) | $381.70M(+130.9%) |
| Jun 2022 | - | $32.10M(-0.3%) | $165.30M(-17.4%) |
| Mar 2022 | - | $32.20M(-29.7%) | $200.20M(-10.7%) |
| Dec 2021 | $224.10M(+58.9%) | $45.80M(-17.0%) | $224.10M(+4.6%) |
| Sep 2021 | - | $55.20M(-17.6%) | $214.30M(+4.6%) |
| Jun 2021 | - | $67.00M(+19.4%) | $204.80M(+18.4%) |
| Mar 2021 | - | $56.10M(+55.8%) | $172.90M(+22.6%) |
| Dec 2020 | $141.00M(+62.3%) | $36.00M(-21.2%) | $141.00M(-0.1%) |
| Sep 2020 | - | $45.70M(+30.2%) | $141.10M(+27.5%) |
| Jun 2020 | - | $35.10M(+45.0%) | $110.70M(+23.4%) |
| Mar 2020 | - | $24.20M(-33.0%) | $89.70M(+3.2%) |
| Dec 2019 | $86.90M(+20.5%) | $36.10M(+135.9%) | $86.90M(+21.3%) |
| Sep 2019 | - | $15.30M(+8.5%) | $71.63M(-13.1%) |
| Jun 2019 | - | $14.10M(-34.1%) | $82.38M(+0.6%) |
| Mar 2019 | - | $21.40M(+2.8%) | $81.89M(+13.6%) |
| Dec 2018 | $72.10M(+31.6%) | $20.82M(-20.1%) | $72.10M(+13.1%) |
| Sep 2018 | - | $26.06M(+91.6%) | $63.72M(+26.3%) |
| Jun 2018 | - | $13.60M(+17.1%) | $50.44M(+9.3%) |
| Mar 2018 | - | $11.62M(-6.7%) | $46.14M(-15.8%) |
| Dec 2017 | $54.80M(-28.1%) | $12.45M(-2.6%) | $54.83M(-12.1%) |
| Sep 2017 | - | $12.78M(+37.4%) | $62.40M(-6.3%) |
| Jun 2017 | - | $9.30M(-54.2%) | $66.62M(-15.0%) |
| Mar 2017 | - | $20.30M(+1.4%) | $78.35M(+2.7%) |
| Dec 2016 | $76.26M(+70.2%) | $20.01M(+17.8%) | $76.26M(+13.1%) |
| Sep 2016 | - | $17.00M(-19.2%) | $67.42M(+4.7%) |
| Jun 2016 | - | $21.03M(+15.5%) | $64.38M(+19.3%) |
| Mar 2016 | - | $18.21M(+62.9%) | $53.94M(+20.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $44.81M(+46.1%) | $11.18M(-19.8%) | $44.81M(-9.8%) |
| Sep 2015 | - | $13.95M(+31.6%) | $49.68M(+21.3%) |
| Jun 2015 | - | $10.60M(+16.7%) | $40.95M(+16.5%) |
| Mar 2015 | - | $9.08M(-43.4%) | $35.16M(+14.6%) |
| Dec 2014 | $30.67M(-27.0%) | $16.05M(+207.5%) | $30.67M(+38.0%) |
| Sep 2014 | - | $5.22M(+8.5%) | $22.22M(-40.4%) |
| Jun 2014 | - | $4.81M(+4.8%) | $37.30M(-4.2%) |
| Mar 2014 | - | $4.59M(-39.6%) | $38.93M(-7.4%) |
| Dec 2013 | $42.02M(-22.0%) | $7.60M(-62.6%) | $42.02M(-11.2%) |
| Sep 2013 | - | $20.30M(+215.0%) | $47.32M(+27.7%) |
| Jun 2013 | - | $6.44M(-16.1%) | $37.05M(-5.5%) |
| Mar 2013 | - | $7.68M(-40.5%) | $39.20M(-27.2%) |
| Dec 2012 | $53.84M(-0.3%) | $12.90M(+28.7%) | $53.84M(-11.5%) |
| Sep 2012 | - | $10.02M(+16.6%) | $60.82M(-10.8%) |
| Jun 2012 | - | $8.59M(-61.5%) | $68.15M(+0.3%) |
| Mar 2012 | - | $22.33M(+12.4%) | $67.92M(+25.7%) |
| Dec 2011 | $54.03M(+144.5%) | $19.87M(+14.5%) | $54.03M(+28.0%) |
| Sep 2011 | - | $17.36M(+107.6%) | $42.21M(+39.5%) |
| Jun 2011 | - | $8.36M(-0.8%) | $30.27M(+18.7%) |
| Mar 2011 | - | $8.43M(+4.6%) | $25.50M(+15.4%) |
| Dec 2010 | $22.10M(-33.6%) | $8.06M(+48.9%) | $22.10M(-32.9%) |
| Sep 2010 | - | $5.41M(+50.3%) | $32.95M(+0.4%) |
| Jun 2010 | - | $3.60M(-28.4%) | $32.82M(-2.2%) |
| Mar 2010 | - | $5.03M(-73.4%) | $33.56M(+0.8%) |
| Dec 2009 | $33.29M(+59.9%) | $18.91M(+258.0%) | $33.29M(+77.8%) |
| Sep 2009 | - | $5.28M(+21.7%) | $18.73M(+7.8%) |
| Jun 2009 | - | $4.34M(-8.7%) | $17.36M(-6.8%) |
| Mar 2009 | - | $4.75M(+9.3%) | $18.64M(-10.5%) |
| Dec 2008 | $20.81M(-52.7%) | $4.35M(+10.9%) | $20.81M(-14.1%) |
| Sep 2008 | - | $3.92M(-30.1%) | $24.24M(-16.9%) |
| Jun 2008 | - | $5.61M(-19.0%) | $29.17M(-15.2%) |
| Mar 2008 | - | $6.93M(-10.8%) | $34.41M(-21.7%) |
| Dec 2007 | $43.97M(+6.6%) | $7.77M(-12.2%) | $43.97M(-2.5%) |
| Sep 2007 | - | $8.85M(-18.4%) | $45.09M(+24.4%) |
| Jun 2007 | - | $10.85M(-34.2%) | $36.24M(+42.8%) |
| Mar 2007 | - | $16.49M(+85.4%) | $25.39M(+185.4%) |
| Dec 2006 | $41.23M(+531.2%) | $8.89M | $8.89M |
| Dec 2005 | $6.53M(-61.7%) | - | - |
| Dec 2004 | $17.07M(+314.1%) | - | - |
| Dec 2003 | $4.12M | - | - |
FAQ
- What is Emergent BioSolutions Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Emergent BioSolutions Inc.?
- What is Emergent BioSolutions Inc. annual CAPEX year-on-year change?
- What is Emergent BioSolutions Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Emergent BioSolutions Inc.?
- What is Emergent BioSolutions Inc. quarterly CAPEX year-on-year change?
- What is Emergent BioSolutions Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Emergent BioSolutions Inc.?
- What is Emergent BioSolutions Inc. TTM CAPEX year-on-year change?
What is Emergent BioSolutions Inc. annual capital expenditures?
The current annual CAPEX of EBS is $22.90M
What is the all-time high annual CAPEX for Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. all-time high annual capital expenditures is $359.50M
What is Emergent BioSolutions Inc. annual CAPEX year-on-year change?
Over the past year, EBS annual capital expenditures has changed by -$28.70M (-55.62%)
What is Emergent BioSolutions Inc. quarterly capital expenditures?
The current quarterly CAPEX of EBS is $3.40M
What is the all-time high quarterly CAPEX for Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. all-time high quarterly capital expenditures is $271.60M
What is Emergent BioSolutions Inc. quarterly CAPEX year-on-year change?
Over the past year, EBS quarterly capital expenditures has changed by -$2.40M (-41.38%)
What is Emergent BioSolutions Inc. TTM capital expenditures?
The current TTM CAPEX of EBS is $11.60M
What is the all-time high TTM CAPEX for Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. all-time high TTM capital expenditures is $381.70M
What is Emergent BioSolutions Inc. TTM CAPEX year-on-year change?
Over the past year, EBS TTM capital expenditures has changed by -$21.00M (-64.42%)